Institutional investors hold a majority ownership of AMGN through the 80.98% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2017, these large investors purchased a net $5.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AZIMUT CAPITAL MANAGEMENT SGR SP... Bought 182.7 Thousand shares of Amgen
STATE STREET GLOBAL ADVISORS LTD... Bought 180.8 Thousand shares of Amgen
LPL FINANCIAL LLC Bought 132.5 Thousand shares of Amgen